Compositions comprising docosapentaenoic acid and methods of use
AssigneeMatinas BioPharma, Inc.
InventorsAbdel Aziz FAWZY, George BOBOTAS, Ihor TERLECKYJ, Roelof RONGEN
Life of this patent
Estimating the term…
Abstract
Orally administrable composition comprising fatty acids comprising docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). The compositions can be used for the treatment or prophylaxis of a variety of conditions, including liver-related conditions.
Claims20
A pharmaceutical composition comprising docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) in an amount of at least 60% of the total amount of the fatty acids present in the composition, wherein the ratio of DPA to DHA (DPA:DHA) is between about 10:1 to about 1:10.
A method of treating, preventing, reducing the occurrence of, and improving symptoms associated with a liver-related disease or condition in a subject in need thereof, comprising administering to the subject a composition comprising docosapentaeoic acid (DPA) and docosahexaenoic acid (DHA) in a daily dosage amount of between 200 mg/day and 8,100 mg/day.
Dependencies are inferred from the claim text.